Innovative drugs that target the central nervous system
NeuroCycle Therapeutics, Inc.
Incorporated
12.04.2016Headquarters
CambridgeSupport
Neurocycle Therapeutics is developing drugs that regulate neuron signaling. Our lead candidate NCT-10004 is being developed for treatment of itch in people and dogs. In addition, we have drug discovery programs in pain and orphan epilepsies.